Ketorolac Tromethamine Injection Shortage: Current Availability and Manufacturer Updates

What’s in Shortage

Ketorolac Tromethamine Injection (Brand Name: KETOROLAC TROMETHAMINE) is currently listed as in shortage. This medication is used within the Analgesia/Addiction therapeutic category. The shortage affects various strengths and presentations of the injection form. This shortage was first posted on March 26, 2018, and was last updated on February 3, 2026.

Which Manufacturers Are Affected

Availability varies significantly by manufacturer and specific product presentation:

• Sagent Pharmaceuticals (866-625-1618):

  • 30 mg/1 mL (NDC 25021-701-01): Available
  • 15 mg/1 mL (NDC 25021-700-01): Available
  • 30 mg/1 mL (NDC 25021-701-02): Available

• Baxter Healthcare (888-229-0001):

  • 30 mg/1 mL (NDC 0338-0072-25): Available
  • 15 mg/1 mL (NDC 0338-0069-10): Available

• Fresenius Kabi USA, LLC (888-386-1300):

  • 15 mg/1 mL (NDC 63323-161-01): Available (Check wholesaler inventory)
  • 30 mg/1 mL (NDC 63323-162-02): Available (Check wholesaler inventory)
  • 30 mg/1 mL (NDC 76045-104-10): Unavailable
  • 60 mg/2 mL (NDC 76045-105-20): Unavailable
  • 15 mg/1 mL (NDC 76045-107-10): Unavailable
  • 30 mg/1 mL (NDC 63323-162-01): Unavailable; next release date not available.

Why There’s a Shortage

No specific reason for the shortage was provided in the current FDA report.

What Patients Should Do

If you are a patient who requires Ketorolac Tromethamine Injection, please consider the following steps:

• Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication availability.
• Speak with your pharmacist: They can check current wholesaler inventory and may have information on which specific presentations are in stock.
• Contact manufacturers: You may use the contact numbers provided above to inquire about the most recent availability status for specific NDC numbers.

Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or pharmacist for medical advice and guidance regarding medication changes or alternatives.

Source

Information provided by the FDA Drug Shortage Database.